Toolkit
Latest project information
HTA - 10/49/01
Cabazitaxel for the second-line treatment of hormone refractory, metastatic prostate cancer
Project title: Cabazitaxel for the second-line treatment of hormone refractory, metastatic prostate cancer
Call to action: 14/135 Batch 13
Research type: Evidence Synthesis
Chief investigator: Professor Matt Stevenson
Contractor: The University of Sheffield
Cost: £65,625.00
Started: June 2011 | Status: Project complete
Links to project documentation
The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.
Background & Research Questions
Why the research is being done and what is being asked
Methods
How the research is being done
Publications & Outputs
What the research produced
Outcomes & Impact
What happened as a result of the research